SUMMARY Extraintestinal pathogenic Escherichia coli (ExPEC) strains are responsible for a
majority of human extraintestinal infections globally, resulting in enormous direct medical …

Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is
challenging, and some of the few active drugs are not available in many countries. For …

Globally, rates of ESBL-producing Enterobacteriaceae are rising. We undertook a literature
review, and present the temporal trends in bla CTX-M epidemiology, showing that bla CTX …

Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in
the 2000s as important human pathogens, have spread extensively throughout the world …

Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

Hosts and bacteria have coevolved over millions of years, during which pathogenic bacteria
have modified their virulence mechanisms to adapt to host defense systems. Although the …

Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of
resistance to oxyimino-cephalosporins evolved by members of the family …

Pathogenic Escherichia coli strains cause a wide variety of intestinal and extraintestinal
infections. The widespread geographical clonal dissemination of intestinal pathogenic E …

Clin Microbiol Infect 2011; 17: 873–880 Abstract Intestinal carriage of extended‐spectrum
beta‐lactamase (ESBL)‐producing bacteria in food‐producing animals and contamination of …